Published by Wanda Rich
Posted on October 12, 2021
The global histology embedding systems market is expected to post substantial gains through 2021, as the need to ascertain disease geneses and ultimately timely disbursement of treatment acquire precedence. This trend has become especially overt in the aftermath of the COVID-19 pandemic. Long-term gains appear equally lucrative, exhibiting robust growth until 2031.
As per this study, histology embedding systems are expected to undergo a major transition, underpinned by rapid digitalization of diagnostic approaches. For instance, in August 2020, UK’s National Health Service (NHS) received a £ 50 million funding from the Department of Health and Social Care to establish three digital pathology and imaging AI centers in Coventry, Leeds and London respectively.
Furthermore, scope is expected to be immense across the cancer diagnostics segment. The American Institute for Cancer Research estimates that lung and breast cancers constituted the bulk of global cancer prevalence in 2018, each contributing 12.3% of the total share, surpassing 4 million cases. Hence, players such as Thermo Fisher are offering advanced solutions, such as the OncomineTM Breast cfDNA Assay, comprising of a complex pool of multiplex PCR primers.
Request Free Demo of this Report https://www.factmr.com/connectus/sample?flag=B&rep_id=3983
Histological Embedding Systems Market: Segmentation
The global Histology Embedding System market can be segmented on the basis of Paraffin Chamber Capacity, Applications, Modularity and End Users.
Based on Paraffin Chamber Capacity, the global Histology Embedding System market is segmented as:
Based on Applications, the global Histology Embedding System market is segmented as:
Based on Modularity, the global Histology Embedding System market is segmented as:
Based on End users, the global Histology Embedding System market is segmented as:
Key Takeaways from Fact.MR’s Histology Embedding Systems Study
Histology Embedding System Market- Prominent Drivers
Histology Embedding System Market- Key Restraints
Discover more about the histology embedding system market with figures and data tables, along with the table of contents. You will also find detailed market segmentation on https://www.factmr.com/report/3983/histology-embedding-system-market
Histology Embedding System Market: Key Players
Some of the key players in the global Histology Embedding System Market are
Histology Embedding System Market: Overview
The rising demand for Histology embedding systems is driven by increasing research in developed regions such as North America and Europe. These regions contribute a very significant amount to healthcare research.
Histology embedding systems have evident usage in histology, pathology, Immunohistochemistry and some other kind’s domains in research and analysis. Histology embedding systems are involved in the very basic and primary steps of analysis and hence the demand of this system. Histology embedding systems are also used in analyzing surgical samples and hence required in hospitals and specialty clinics.
More Insights on the Histology Embedding System Market
The research study on the histology embedding system treatment market by Fact.MR includes an in-depth analysis of major demand-driving factors and trends and a comprehensive evaluation of crucial aspects that are projected to carve the growth of the histology embedding system market. Market statistics have been elucidated based on paraffin chamber capacity (2L-3L, 4L-5L, 5L, 6L and 7L), application (histology, histopathology, plant tissue culture, molecular profiling, diagnostics, cancer research and immunohistochemistry), modularity (single module system, 2 module system and 3 module system) and end-users (hospitals, specialty clinics, cancer research labs, pathological labs, histopathological labs and plant tissue cultures) across six major regions (North America, Latin America, Europe, East Asia, South Asia and Middle East & Africa).
The report covers exhaustive analysis on:
Explore Fact.MR’s Coverage on the Healthcare Domain:
Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.
At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.
Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness upsurge growth during the year 2021-2031.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
The post Breast Cancer Research to Spearhead Bulk of Histology Embedding Systems Market Expansion appeared first on Latest Market Reports.
The global histology embedding systems market is expected to post substantial gains through 2021, as the need to ascertain disease geneses and ultimately timely disbursement of treatment acquire precedence. This trend has become especially overt in the aftermath of the COVID-19 pandemic. Long-term gains appear equally lucrative, exhibiting robust growth until 2031.
As per this study, histology embedding systems are expected to undergo a major transition, underpinned by rapid digitalization of diagnostic approaches. For instance, in August 2020, UK’s National Health Service (NHS) received a £ 50 million funding from the Department of Health and Social Care to establish three digital pathology and imaging AI centers in Coventry, Leeds and London respectively.
Furthermore, scope is expected to be immense across the cancer diagnostics segment. The American Institute for Cancer Research estimates that lung and breast cancers constituted the bulk of global cancer prevalence in 2018, each contributing 12.3% of the total share, surpassing 4 million cases. Hence, players such as Thermo Fisher are offering advanced solutions, such as the OncomineTM Breast cfDNA Assay, comprising of a complex pool of multiplex PCR primers.
Request Free Demo of this Report https://www.factmr.com/connectus/sample?flag=B&rep_id=3983
Histological Embedding Systems Market: Segmentation
The global Histology Embedding System market can be segmented on the basis of Paraffin Chamber Capacity, Applications, Modularity and End Users.
Based on Paraffin Chamber Capacity, the global Histology Embedding System market is segmented as:
Based on Applications, the global Histology Embedding System market is segmented as:
Based on Modularity, the global Histology Embedding System market is segmented as:
Based on End users, the global Histology Embedding System market is segmented as:
Key Takeaways from Fact.MR’s Histology Embedding Systems Study
Histology Embedding System Market- Prominent Drivers
Histology Embedding System Market- Key Restraints
Discover more about the histology embedding system market with figures and data tables, along with the table of contents. You will also find detailed market segmentation on https://www.factmr.com/report/3983/histology-embedding-system-market
Histology Embedding System Market: Key Players
Some of the key players in the global Histology Embedding System Market are
Histology Embedding System Market: Overview
The rising demand for Histology embedding systems is driven by increasing research in developed regions such as North America and Europe. These regions contribute a very significant amount to healthcare research.
Histology embedding systems have evident usage in histology, pathology, Immunohistochemistry and some other kind’s domains in research and analysis. Histology embedding systems are involved in the very basic and primary steps of analysis and hence the demand of this system. Histology embedding systems are also used in analyzing surgical samples and hence required in hospitals and specialty clinics.
More Insights on the Histology Embedding System Market
The research study on the histology embedding system treatment market by Fact.MR includes an in-depth analysis of major demand-driving factors and trends and a comprehensive evaluation of crucial aspects that are projected to carve the growth of the histology embedding system market. Market statistics have been elucidated based on paraffin chamber capacity (2L-3L, 4L-5L, 5L, 6L and 7L), application (histology, histopathology, plant tissue culture, molecular profiling, diagnostics, cancer research and immunohistochemistry), modularity (single module system, 2 module system and 3 module system) and end-users (hospitals, specialty clinics, cancer research labs, pathological labs, histopathological labs and plant tissue cultures) across six major regions (North America, Latin America, Europe, East Asia, South Asia and Middle East & Africa).
The report covers exhaustive analysis on:
Explore Fact.MR’s Coverage on the Healthcare Domain:
Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.
At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.
Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness upsurge growth during the year 2021-2031.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
The post Breast Cancer Research to Spearhead Bulk of Histology Embedding Systems Market Expansion appeared first on Latest Market Reports.
Explore more articles in the Research Reports category
